IOPtima Ltd. develops, produces and distributes novel surgical treatments for Glaucoma
The IOPtiMate™, is an innovative surgical system performing CO2 Laser Assisted Filtration Surgery.
As an alternative to conventional surgery, the IOPtiMate™ is designed to provide long-term relief from excessive intraocular pressure and reduce reliance on anti-Glaucoma drugs.
As the IOPtiMate™CO2 Laser Assisted Filtration Surgery is a non-penetrating filtration procedure, it significantly reduces the known risks of intra- and post-operative complications as well as the follow-up interventions commonly associated with penetrating surgical alternatives.
- Minimally-invasive
- Excellent safety profile
- Long-term efficacy
- Reduces reliance on drug compliance
- Simple to perform
- Short learning curve
- Reproducible results
The system is CE approved, commercially available and used in major European medical centers
Caution:
The IOPtiMate™ is not FDA approved for investigational use and/or
sale in the USA
